Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Active Not Recruiting1
Enrolling By Invitation1
Unknown1

Clinical Trials (3)

Showing 3 of 3 trials
NCT01652092Not ApplicableActive Not Recruiting

Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies

NCT01346150Unknown

Patients Treated for SCID (1968-Present)

NCT01186913Enrolling By Invitation

Natural History Study of SCID Disorders

Showing all 3 trials

Research Network

Activity Timeline